CClinicalTrials.gg
CompletedNCT04958707Updated Aug 11, 2025Results posted

A Mobile Phone-based Intervention on Dementia Patients' Caregivers in Vietnam

An interventional study of Information including knowledge and skills related to dementia patient care and Usual care in Dementia, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Completed at 2 sites in Vietnam. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Background: The growing number of older people with dementia increases demand on informal caregivers who lack information and skills, leading to a high psychological burden in care provision. The proposed smartphone app-based intervention will provide a convenient and feasible solution for reducing depression, stress, and anxiety among dementia carers in Vietnam. This study aims to: (1) understanding the information and skills required by informal carers to populate the content of the intervention and (2) test the clinical feasibility of the intervention and feasibility of a fully- power randomized controlled trial.

Methods: The setting of this study is the geriatrics department in Gia Dinh People's hospital in Ho Chi Minh City. The eligible participants are the informal caregivers of patients with dementia living in the community, who use smartphones. Phase 1 will involve 20 interviews, conducted with 20 dementia carers to determine what information and skills they need most. These findings will be used to design the content of the intervention, which will comprise 8 weekly, online, psycho-educational, group sessions hosted on the Zalo app. Phase 2: using a pilot randomized control trial design, 60 participants will be assigned to the intervention or control group by the block randomization method with a ratio of 1:1. The participants will complete questionnaires at baseline, post-intervention and 3 month post-intervention. Outcome measures include DASS21 (Depression, anxiety and stress 21), dementia understanding, perceived social support, and caregiver's perceived burden. The primary outcome is the feasibility of the intervention and a future fully-power randomized controlled trial including acceptability and perceived effectiveness of the intervention and the rate of recruitment, retention, and completion of assessments.

Read the detailed description

The study has two phases: the co-design of the content of the intervention (phase 1) and the randomized controlled trial phase (phase 2). The setting and the participants' eligibility criteria are the same for the two phases.

Phase 1 Design: a qualitative study will be conducted on 20 caregivers of patients with dementia to identify what information they most require.

Method: 20 face-to-face interviews will be held and guided by a trained geriatrician, in a private room in the geriatrics department. The open-ended questions are used, including "what difficulties are the participant facing in taking care of the patient with dementia?", "what information do the participant need most?". Each participant will be free to share thoughts. The interviews will be audio-recorded and fully transcribed.

Data analysis: The investigator will use inductive thematic content analysis. The eight most common issues in which the carers need providing information will be determined to shape for the intervention in phase 2.

Phase 2 Study design A parallel-group randomized controlled pilot trial will be used with equal randomization of 1:1 to test the feasibility and the acceptability of the smartphone app-based intervention. Sixty dementia carers, who meet the eligible criteria and are provided written informed consent, will be enrolled in the study and will be allocated to the intervention or usual care group.

Randomization The eligible participants will be assigned to the intervention or control group by an independent statistician, using the block randomization method (blocks of 4).

Intervention The participants in the intervention group will be added to a chat room in the Zalo app, created and managed by one investigator, which is named The Dementia Caregiver Support group. Weekly, the investigator will post one of the eight topics identified in Phase 1. Before posting the information, the investigator will ask the participants what topic they would like to read and discuss the week after by voting the answer. The posted information will be based on evidence-based resources and consulted by geriatricians, the neurologist, and the psychologist who specialize in dementia. Immediately after posting the topic, one investigator will call the participants to ensure the participants read and understand the post. The chat group monitor will also collect the questions or comments from the carers who are encouraged to share feelings or experiences with relevant questions. Then the investigator will post the answers after consulting with the experts.

Usual care: The participants in the control group will be introduced to the website Alzheimer.org to search for eligible information Procedure The characteristics of the participants (age, gender, educational level, relationship to the care recipient, time of care, etc.) and other assessments will be collected by an independent investigator, who will be blinded through the study.

Measures The participants will perform the Depression, anxiety and stress scale 21 (DASS21) questionnaire via phone call interviews. DASS21 scale contains 21 items, evaluating 3 subscales including depression, anxiety, and stress states over the past week. Higher scores indicate more severity of emotional states. Dementia understanding of the participants will be evaluated at baseline and post-intervention by a questionnaire, originating from the Northern Ireland Life and Time Survey, which was translated into Vietnamese. This questionnaire contains 7 items, for example, "dementia is a normal part of aging" or "dementia can be cured". The response options will be completed with yes/no choices. Four or fewer correct answers will be coded as low understanding, five correct answers medium understanding, and six or more answers as high understanding.

Perceived social support will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS), comprising 12 self-report items assessing the perceived support from family, friends, or significant others (eg, "There is a person who is around me when I am in need). Each item is scored from 1 (very strongly disagree) to 7 (very strongly agree), based on a 7-point Likert scale. Higher scores indicate higher degrees of perceived social support. This scale will be translated and adapted into Vietnamese.

The caregiver's perceived burden will be evaluated usingthe Zarit 4-item burden interview. Each item is scored from 0 to 4, and higher scores indicate higher levels of burden.

Outcome measurements will be assessed face-to-face at baseline and via phone calls at immediate post-intervention and 3-month follow-up post-intervention.

02

Conditions studied

  • Dementia

Browse trials for

03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's enrollment of 60 is below the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 118 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being the primary caregivers of patients with dementia for at least the past 6 months and will continue to be for the next 6 months of the intervention. Dementia patients are those who have been diagnosed with dementia for at least 6 months and are living in the community.
  • Being able to read and understand Vietnamese (at least primary education), and willing to participate in the study.
  • Having a smartphone that has the Zalo app or willing to have this Zalo app be installed (there will be short training of using Zalo for new users)
  • Aged ≥ 18 years

Exclusion criteria

Exclusion Criteria:

  • Having any acute diseases or cognitive impairment (screening by Mini-Cog),
  • Having vision or hearing impairment
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Informational support group

    The participants in the intervention group will be added to a chat group in the Zalo app, created and managed by one investigator, which is named The Dementia Caregiver Support group. Weekly, the investigator will post one of the topics identified in Phase 1. Before posting the information, the investigator will ask the participants what topic they would like to read and discuss the week after by voting the answer. The posted information will be based on evidence-based resources and consulted by geriatricians, the neurologist, and the psychologist who specialize in dementia. Immediately after posting the topic, one investigator will call the participants to ensure they read and understand the post. The chat group monitor will also collect the questions or comments from the carers who are encouraged to share their feelings or experiences with relevant questions. Then the monitor will post the answers after consulting with the experts.

    Other: Information including knowledge and skills related to dementia patient care

  • Active comparator
    Controlled group

    The participants will receive usual care, introduced to the website Alzheimer.org to search for eligible information.

    Other: Usual care

Interventions

  • OtherInformation including knowledge and skills related to dementia patient care

    The intervention will be administered to the participants via a smartphone app (Zalo app). Weekly, the investigator will post one of the eight topics identified in Phase 1 in the chat room. After posting the topic, one investigator will call the participants to ensure they read and understand the contents.

  • OtherUsual care

    Caregivers will be introduce to the website www.alzheimer.org to search for eligible information

06

What researchers measure

Primary outcomes

  1. Phase 1: The Most Common Topics Related to Dementia Patient Care Skills

    The investigators will address these issues by in-deep interviews in phase 1. The most common topics the participants need providing will be listed

    Time frame: 4 months

  2. Phase 2: The Rate of Recruitment, Retention and Completeness of Outcome Measurements

    The rate of recruitment will be identified by the percentage of participants who agree to participate in the study. The rate of retention will be identified by the percentage of participants who stay in the study. The rate of completeness of the outcome measurements is the percentage of participants who agreed to answer the questionnaires during the study. The rate of recruitment, the rate of participant retention, and the rate of completeness of outcome measurements will be reported in percentages.

    Time frame: 9 months

Secondary outcomes

  1. Phase 2: Depression, Anxiety and Stress Levels of the Caregivers

    The participants will be evaluated by the Depression, anxiety, and stress 21 scale. The minimum score is 0, and the maximum score is 126. The higher scores indicate worse outcome

    Time frame: Baseline, post-intervention (6 months) and three-month follow-up (9 months)

  2. Dementia Understanding of the Caregivers About Dementia

    The participant will be evaluated by the questionnaire originating from Northern Ireland Life and Time Survey questionnaire which includes 7 items. The score will range from 0 to 7. A higher score indicates a better outcome.

    Time frame: Baseline, post-intervention (6 months) and three-months follow-up (9 months)

  3. Phase 2: Perceived Social Support of the Caregivers

    The participant will be evaluated by the Multidimensional perceived social support scale (MSPSS) which includes 12 items. Each item is scored from 1 (very strongly disagree) to 7 (very strongly agree), based on a 7-point Likert scale. The minimum score is 12 and the maximum score is 84. Higher scores indicate higher degrees of perceived social support

    Time frame: Baseline, post-intervention (6 months), and three-month follow-up (9 months)

  4. Phase 2: Perceived Burden

    The participants will be evaluated by the Zarit 4-item burden interview, including 4 items. Each item is scored from 1 to 4. The total score ranges from 0 to 16. A Higher score indicates a higher feeling of burden.

    Time frame: Baseline, post-intervention (6 months), and three-month follow-up (9 months)

07

Results

Posted Aug 11, 2025

Participant flow

Post Intervention
Participant flow — Post Intervention
MilestonePhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupPhase 1: Qualitative Interviews
Started303020
Completed293020
Not completed100
Withdrew: Withdrawal by subject100
3 Months Follow- up
Participant flow — 3 Months Follow- up
MilestonePhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupPhase 1: Qualitative Interviews
Started29300
Completed27270
Not completed230
Withdrew: Lost to follow-up030
Withdrew: Withdrawal by subject200

Outcome measures

PrimaryPhase 1: The Most Common Topics Related to Dementia Patient Care Skills

The investigators will address these issues by in-deep interviews in phase 1. The most common topics the participants need providing will be listed

Time frame:
4 months
Reported as:
Number · Participants
Phase 1: The Most Common Topics Related to Dementia Patient Care Skills
ParticipantsThe Information Needed by the Caregivers
Providing personal care15
Managing behavior changes in care recipients.12
Help-seeking strategies for caregivers18
Self-care for caregivers to maintain their own well-being18
Dementia progress and caring skills17
Managing comorbidities such as pressure injuries, falls, and infections in care recipients15
PrimaryPhase 2: The Rate of Recruitment, Retention and Completeness of Outcome Measurements

The rate of recruitment will be identified by the percentage of participants who agree to participate in the study. The rate of retention will be identified by the percentage of participants who stay in the study. The rate of completeness of the outcome measurements is the percentage of participants who agreed to answer the questionnaires during the study. The rate of recruitment, the rate of participant retention, and the rate of completeness of outcome measurements will be reported in percentages.

Time frame:
9 months
Reported as:
Number · participants
Phase 2: The Rate of Recruitment, Retention and Completeness of Outcome Measurements
participantsInformational Support GroupControl Group
The recruitment rate3030
Retention rate2727
Completeness of outcome measurements2727
SecondaryPhase 2: Depression, Anxiety and Stress Levels of the Caregivers

The participants will be evaluated by the Depression, anxiety, and stress 21 scale. The minimum score is 0, and the maximum score is 126. The higher scores indicate worse outcome

Time frame:
Baseline, post-intervention (6 months) and three-month follow-up (9 months)
Reported as:
Mean · points
Phase 2: Depression, Anxiety and Stress Levels of the Caregivers
pointsInformational Support Group (Intervention Group)Control Group
Baseline36 ± 23.430.1 ± 19.2
Postintervention (6 months)17.3 ± 12.534.3 ± 15.5
3 months follow-up (9 months)16.5 ± 9.537 ± 15.8
SecondaryDementia Understanding of the Caregivers About Dementia

The participant will be evaluated by the questionnaire originating from Northern Ireland Life and Time Survey questionnaire which includes 7 items. The score will range from 0 to 7. A higher score indicates a better outcome.

Time frame:
Baseline, post-intervention (6 months) and three-months follow-up (9 months)
Reported as:
Mean · points
Dementia Understanding of the Caregivers About Dementia
pointsInformational Support GroupControl Group
Baseline3.8 ± 1.53.5 ± 1.2
Postintervention5.8 ± 1.32.9 ± 0.9
3 months follow-up6.2 ± 1.33.1 ± 0.9
SecondaryPhase 2: Perceived Social Support of the Caregivers

The participant will be evaluated by the Multidimensional perceived social support scale (MSPSS) which includes 12 items. Each item is scored from 1 (very strongly disagree) to 7 (very strongly agree), based on a 7-point Likert scale. The minimum score is 12 and the maximum score is 84. Higher scores indicate higher degrees of perceived social support

Time frame:
Baseline, post-intervention (6 months), and three-month follow-up (9 months)
Reported as:
Mean · score on a scale
Phase 2: Perceived Social Support of the Caregivers
score on a scaleInformation Support GroupControl Group
Baseline9.1 ± 3.78.9 ± 3.1
Postintervention6.3 ± 2.99.8 ± 2.4
Three-month follow-up6.2 ± 2.49.7 ± 2.0
SecondaryPhase 2: Perceived Burden

The participants will be evaluated by the Zarit 4-item burden interview, including 4 items. Each item is scored from 1 to 4. The total score ranges from 0 to 16. A Higher score indicates a higher feeling of burden.

Time frame:
Baseline, post-intervention (6 months), and three-month follow-up (9 months)
Reported as:
Mean · score on a scale
Phase 2: Perceived Burden
score on a scaleInformational Support GroupControl Group
Baseline9.1 ± 3.78.9 ± 3.1
Postintervention6.2 ± 2.99.8 ± 2.4
Three-month follow-up6.2 ± 2.49.7 ± 2.0

Adverse events

Collected over 10 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Phase 1: Qualitative Interviews0/20 (0%)0/20 (0%)0/20 (0%)
Phase 2: Informational Support Group (Intervention Group)0/30 (0%)0/30 (0%)0/30 (0%)
Phase 2: Control Group0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Phase 1: Qualitative InterviewsPhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupTotal
Mean55.6 ± 10.156.1 ± 10.154.1 ± 8.155.1 ± 9.0
Sex: Female, Male
Sex: Female, Male(Participants)Phase 1: Qualitative InterviewsPhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupTotal
Female18232465
Male27615
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Phase 1: Qualitative InterviewsPhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupTotal
Hispanic or Latino0000
Not Hispanic or Latino20303080
Unknown or Not Reported0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Phase 1: Qualitative InterviewsPhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupTotal
American Indian or Alaska Native0000
Asian20303080
Native Hawaiian or Other Pacific Islander0000
Black or African American0000
White0000
More than one race0000
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(Participants)Phase 1: Qualitative InterviewsPhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupTotal
Vietnam20303080
Marital status
Marital status(Participants)Phase 1: Qualitative InterviewsPhase 2: Informational Support Group (Intervention Group)Phase 2: Control GroupTotal
Having a partner12161947
Single/widowed/divorce8141133
08

Study locations

2 sites
  • Gia Dinh People's Hospital
    Ho Chi Minh City, 70000, Vietnam
  • University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, 70000, Vietnam
09

References and documents

Publications

  • McParland P, Devine P, Innes A, Gayle V. Dementia knowledge and attitudes of the general public in Northern Ireland: an analysis of national survey data. Int Psychogeriatr. 2012 Oct;24(10):1600-13. doi: 10.1017/S1041610212000658. Epub 2012 May 17. PubMed 22591515 ↗
  • Bruwer B, Emsley R, Kidd M, Lochner C, Seedat S. Psychometric properties of the Multidimensional Scale of Perceived Social Support in youth. Compr Psychiatry. 2008 Mar-Apr;49(2):195-201. doi: 10.1016/j.comppsych.2007.09.002. Epub 2007 Dec 21. PubMed 18243894 ↗
  • Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43. doi: 10.1016/0005-7967(94)00075-u. PubMed 7726811 ↗
  • Bedard M, Molloy DW, Squire L, Dubois S, Lever JA, O'Donnell M. The Zarit Burden Interview: a new short version and screening version. Gerontologist. 2001 Oct;41(5):652-7. doi: 10.1093/geront/41.5.652. PubMed 11574710 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 21, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Share the results of the study

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04958707
Lead sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Collaborators
National Geriatric Hospital, University of California, Davis
Responsible party
Nguyen Tran To Tran (Lecturer of Geriatrics Department, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
Jul 12, 2021
Start date
Dec 18, 2023
Primary completion
Jul 7, 2024
Completion
Oct 25, 2024
Results posted
Aug 11, 2025
Last update
Aug 11, 2025

Study contacts

The Than, Dr
principal investigator · University of Medicine and Pharmacy at Ho Chi Minh City

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion